lobbying_activities: 2963968

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2963968	7a784a19-26c8-468e-a425-39951d60fd54	Q1	CAPITOL COUNSEL LLC	313715	PHARMAPOTHECA A, INC.	2023	first_quarter	PHA	Advocacy to encourage FDA to establish science-based limits to control contamination of a potential genotoxic trace impurity in amphetamine-based ADHD dosage forms.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2023-04-18T11:45:29-04:00